Enhancement of tumorigenic, metastatic and in vitro invasive capacity of rat mammary tumor cells by transforming growth factor-beta.

[1]  B. Pasche.  Role of transforming growth factor beta in cancer , 2001, Journal of cellular physiology.

[2]  K. Miyazono.  TGF-β/SMAD Signaling and Its Involvement in Tumor Progression , 2000 .

[3]  J. Dichgans,et al.  Transforming growth factors beta(1) (TGF-beta(1)) and TGF-beta(2) promote glioma cell migration via Up-regulation of alpha(V)beta(3) integrin expression. , 2000, Biochemical and biophysical research communications.

[4]  T. Inoue,et al.  TGF-beta1 secreted by gastric fibroblasts up-regulates CD44H expression and stimulates the peritoneal metastatic ability of scirrhous gastric cancer cells. , 2000, International journal of oncology.

[5]  A. Angelucci,et al.  Osteoblast conditioned media contain TGF‐β1 and modulate the migration of prostate tumor cells and their interactions with extracellular matrix components , 1999, International journal of cancer.

[6]  A. Skubitz,et al.  CD44 and β1 Integrin Mediate Ovarian Carcinoma Cell Adhesion to Peritoneal Mesothelial Cells , 1999 .

[7]  K. Matsumoto,et al.  Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line , 1999, British Journal of Cancer.

[8]  Y. Maehara,et al.  Role of transforming growth factor-beta 1 in invasion and metastasis in gastric carcinoma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  L. Gold.  The role for transforming growth factor-beta (TGF-beta) in human cancer. , 1999, Critical reviews in oncogenesis.

[10]  J. Hamada,et al.  Inhibitory effects of malotilate on invasion and metastasis of rat mammary carcinoma cells by modifying the functions of vascular endothelial cells. , 1998, British Journal of Cancer.

[11]  R. Kannagi,et al.  Involvement of adhesion molecules in metastasis of SW1990, human pancreatic cancer cells , 1998, Journal of surgical oncology.

[12]  J. Massagué.  TGF-beta signal transduction. , 1998, Annual review of biochemistry.

[13]  R. Kannagi,et al.  Adhesion molecules and TGF‐β1 are involved in the peritoneal dissemination of NUGC‐4 human gastric cancer cells , 1997 .

[14]  T. Hasuma,et al.  Transforming Growth Factor‐β and Hepatocyte Growth Factor Produced by Gastric Fibroblasts Stimulate the Invasiveness of Scirrhous Gastric Cancer Cells , 1997, Japanese journal of cancer research : Gann.

[15]  M. Yashiro,et al.  CD44H Plays an Important Role in Peritoneal Dissemination of Scirrhous Gastric Cancer Cells , 1996, Japanese journal of cancer research : Gann.

[16]  H. Moses,et al.  Regulation of differentiation by TFG-β , 1996 .

[17]  M. Kitajima,et al.  Therapeutic efficacy of pamidronate in combination with chemotherapy to bone metastasis of breast cancer in a rat model. , 1996, Surgical oncology.

[18]  Y. Matsuzawa,et al.  High levels of transforming growth factor beta 1 in patients with colorectal cancer: association with disease progression. , 1996, Gastroenterology.

[19]  K. Kinzler,et al.  Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. , 1995, Cancer research.

[20]  K. Kinzler,et al.  Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. , 1995, Science.

[21]  H. Moses,et al.  Transforming Growth Factor β and Cell Cycle Regulation , 1995 .

[22]  J. Hamada,et al.  Enhanced effect of epidermal growth factor on pulmonary metastasis and in vitro invasion of rat mammary carcinoma cells. , 1995, Cancer letters.

[23]  G. Pilkington,et al.  Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor beta 1. , 1994, British Journal of Cancer.

[24]  J. Hamada,et al.  Enhancement of Tumorigenicity and Invasion Capacity of Rat Mammary Adenocarcinoma Cells by Epidermal Growth Factor and Transforming Growth Factor‐β , 1993, Japanese journal of cancer research : Gann.

[25]  A. Greenberg,et al.  Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma. , 1993, The American journal of pathology.

[26]  T. Stukel,et al.  Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer. , 1992, Cancer Research.

[27]  J. Hamada,et al.  Progression of Weakly Malignant Clone Cells Derived from Rat Mammary Carcinoma by Host Cells Reactive to Plastic Plates , 1992, Japanese journal of cancer research : Gann.

[28]  D. Mooradian,et al.  Effects of transforming growth factor-beta 1 on human pulmonary adenocarcinoma cell adhesion, motility, and invasion in vitro. , 1992, Journal of the National Cancer Institute.

[29]  N. Rosen,et al.  Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions. , 1991, Cancer research.

[30]  F. Orr,et al.  Chemotactic activity of bone and platelet-derived TGF-beta for bone-metastasizing rat Walker 256 carcinosarcoma cells. , 1990, Invasion & metastasis.

[31]  H. Ohigashi,et al.  In vitro Invasion of Endothelial Cell Monolayer by Rat Ascites Hepatoma Cells , 1989, Japanese journal of cancer research : Gann.

[32]  M. Mukai,et al.  Potentiation of Invasive Capacity of Rat Ascites Hepatoma Cells by Transforming Growth Factor‐β , 1989, Japanese journal of cancer research : Gann.

[33]  G. Nicolson,et al.  Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. , 1987, Cancer research.

[34]  G. Nicolson,et al.  Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression. , 1987, Cancer research.

[35]  P. Nowell.  Mechanisms of tumor progression. , 1986, Cancer research.

[36]  M. Mukai,et al.  Interaction of rat ascites hepatoma cells with cultured mesothelial cell layers: a model for tumor invasion. , 1986, Cancer research.

[37]  M. Sporn,et al.  Type beta transforming growth factor: a bifunctional regulator of cellular growth. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Sporn,et al.  New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[39]  G. Albrecht-Buehler,et al.  The phagokinetic tracks of 3T3 cells , 1977, Cell.

[40]  L. R. Foulds,et al.  Tumor Progression: Guest Editorial , 1957 .